Literature DB >> 32297348

Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.

Shaun Giancaterino1, Marin Nishimura1, Ulrika Birgersdotter-Green1, Kurt S Hoffmayer1, Frederick T Han1, Farshad Raissi1, Gordon Ho1, David Krummen1, Gregory K Feld1, Jonathan C Hsu1.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is frequently present in patients with heart failure (HF) and an implantable cardioverter-defibrillator (ICD). This study aims to identify clinical factors associated with a baseline history of AF in ICD recipients, and compares subsequent clinical outcomes in those with and without a baseline history of AF.
METHODS: We studied 566 consecutive first-time ICD recipients at an academic center between 2011 and 2018. Logistic regression multivariable analyses were used to identify clinical factors associated with a baseline history of AF at the time of ICD implant. Cox-proportional hazard regression models were constructed for multivariate analysis to examine associations between a baseline history of AF with subsequent clinical outcomes, including ICD therapies, HF readmission, and all-cause mortality.
RESULTS: Of all patients, 201 (36%) had a baseline history of AF at the time of ICD implant. In multivariate analyses, clinical factors associated with a baseline history of AF included hypertension, valvular heart disease, body weight, PR interval, and serum creatinine level. After multivariate adjustment for potential confounders, a baseline history of AF was associated with an increased risk of anti-tachycardia pacing (HR = 1.84, 95% CI = 1.19-2.85, P = .006), appropriate ICD shocks (HR = 1.80, 95% CI = 1.05-3.09, P = .032), and inappropriate ICD shocks (HR = 3.72, 95% CI = 1.7-7.77, P = .0001), but not other adverse outcomes.
CONCLUSION: Among first-time ICD recipients, specific clinical characteristics were associated with a baseline history of AF at the time of ICD implant. After adjustment for potential confounders, a baseline history of AF was associated with a higher risk of all ICD therapies in follow-up.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  atrial fibrillation; heart failure; implantable cardioverter-defibrillator; inappropriate shock

Mesh:

Year:  2020        PMID: 32297348      PMCID: PMC7299732          DOI: 10.1111/pace.13919

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  24 in total

1.  Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.

Authors:  Michiel Rienstra; Marcelle D Smit; Wybe Nieuwland; Eng S Tan; Ans C P Wiesfeld; Rutger L Anthonio; Maarten P Van den Berg; Dirk J Van Veldhuisen; Isabelle C Van Gelder
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

2.  Predictors of new onset atrial fibrillation in patients with heart failure.

Authors:  Niall G Campbell; Emily J Cantor; Vinit Sawhney; Edward R Duncan; Chiara DeMartini; Victoria Baker; Ihab G Diab; Mehul Dhinoja; Mark J Earley; Simon Sporton; L Ceri Davies; Richard J Schilling
Journal:  Int J Cardiol       Date:  2014-05-17       Impact factor: 4.164

3.  Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.

Authors:  C Jan Willem Borleffs; Johannes B van Rees; Guido H van Welsenes; Enno T van der Velde; Lieselot van Erven; Jeroen J Bax; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

4.  Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.

Authors:  Giuseppe Boriani; Antonis S Manolis; Raymond Tukkie; Lluis Mont; Helmut Pürerfellner; Massimo Santini; Giuseppe Inama; Paolo Serra; Michele Gulizia; Igor Vasilyevich Samoilenko; Claudia Wolff; Reece Holbrook; Federica Gavazza; Luigi Padeletti
Journal:  Heart Rhythm       Date:  2015-02-19       Impact factor: 6.343

5.  Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.

Authors:  Marcelle D Smit; Pascal F H M Van Dessel; Michiel Rienstra; Wybe Nieuwland; Ans C P Wiesfeld; Eng S Tan; Rutger L Anthonio; Dirk J Van Veldhuisen; Isabelle C Van Gelder
Journal:  Europace       Date:  2006-08       Impact factor: 5.214

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

8.  Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.

Authors:  M J Pekka Raatikainen; David O Arnar; Katja Zeppenfeld; Jose Luis Merino; Karl-Heinz Kuck; Gerhardt Hindricks
Journal:  Europace       Date:  2015-08       Impact factor: 5.214

9.  Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.

Authors:  David Birnie; Harrison Hudnall; Bernd Lemke; Kazutaka Aonuma; Kathy Lai-Fun Lee; Maurizio Gasparini; John Gorcsan; Jeffrey Cerkvenik; David O Martin
Journal:  Heart Rhythm       Date:  2017-09-09       Impact factor: 6.343

10.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.